retatrutide dosing frequency clinical trials Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Dosing Guide for Researchers
Description
Telehealth visits are available
the European Medicines Agency noted a shortage of GLP-1 drugs since 2022 driven by off-label demand
Scirica BM, Braunwald E, Raz I, et al
A 2025 study published in JAMA Network Open found that most patients with obesity discontinue GLP-1 therapy within a year, particularly those without type 2 diabetes 1
If you are exclusively breastfeeding a newborn, your body is doing a high-demand job
